G6PC1 and nonpapillary renal cell carcinoma: In addition, low G6Pase expression was significantly correlated with poor prognosis (P < 0.0001, HR = 0.316) and aggressive progression (P < 0.0001, HR = 0.414) in 322 ccRCC patients from FUSCC cohort (Figure 6C and D).